Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The RAD51–single-stranded DNA (ssDNA) nucleoprotein filament is a right-handed helical assembly that serves as the essential catalytic intermediate in homologous recombination (HR) [1, 3, 6]. It is formed when RAD51 recombinase monomers polymerize onto ssDNA, a process regulated by mediator proteins such as BRCA2 and the RAD51 paralogs, which assist in displacing replication protein A (RPA) from the DNA [1, 12, 15, 21]. Once assembled, the filament performs a homology search within double-stranded DNA and catalyzes strand invasion to form a displacement loop (D-loop), enabling high-fidelity repair of double-strand breaks [6, 12, 13, 14]. Additionally, the filament plays a critical role in protecting stalled replication forks from degradation, thereby preserving genomic integrity during S-phase [3, 12, 18]. In many human cancers, RAD51 is overexpressed, leading to hyperactive HR that confers resistance to DNA-damaging chemotherapy and ionizing radiation [2, 4, 7, 16]. Therapeutic strategies targeting this filament include small molecules that inhibit its assembly, disrupt protomer interactions, or block strand exchange, with the goal of sensitizing tumor cells to conventional treatments, particularly in the context of synthetic lethality [4, 7, 9, 11].
Inhibition of RAD51-ssDNA nucleoprotein filament assembly, disruption of RAD51 protomer-protomer interactions, inhibition of DNA strand exchange, and stimulation of filament formation.
9 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RAD51-single-stranded DNA nucleoprotein filament (RAD51-ssDNA filament) (RAD51-ssDNA filament).